Queen Mary researchers ID osteoarthritis treatment; MGH team studies tau; Checkpoint researchers explore resistance;

> A drug that disrupts the length of the cell's antennae, called primary cilia, may be effective as a treatment for osteoarthritis, according to bioengineers from Queen Mary University of London. Release

> A team at Massachusetts General Hospital have been exploring how tau tangles associated with Alzheimer's spread in the brain. Release

> Investigators at the University of Michigan say they've shed new light on explaining why many patients don't respond to a checkpoint inhibitor. Release

> Researchers ID'd 1,450 genes which been linked to the ageing process. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.